Biosergen AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Holding, Public
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://biosergen.net
Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Biosergen AS
- Target Recruit Count
- 15
- Registration Number
- NCT06678113
- Locations
- 🇮🇳
JSS Medical Research Asia Pacific Private Limited, Dehli, Haryana, India
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Phase 1
Recruiting
- Conditions
- Invasive Fungal Infections
- Interventions
- Drug: BSG005 or placebo
- First Posted Date
- 2021-06-10
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Biosergen AS
- Target Recruit Count
- 72
- Registration Number
- NCT04921254
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath